89bio Inc (ETNB) Return on Investment ROI from the second quarter of 2025 to second quarter of 2024 and for the year 2025, average high and low, overall ranking from Jun 30 2025 to Jun 30 2024 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
89bio Inc   (NASDAQ: ETNB)


89bio Inc's ROI from its second quarter of 2025 to the second quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is 89bio Inc's ROI in the second quarter of 2025?
89bio Inc recorded a cumulative net loss of $-450 million during 12 months ending in the second quarter of 2025, resulting in a negative return on investment (ROI) of -86.88%.

Within the Healthcare sector 615 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2025 from 3048 to 3699.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter
Y / Y Investment Change TTM -0.4 % 2.1 % 0.15 % 33.73 % 63.13 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 564 647 443 419 540
Return On Investment (TTM) -86.88 % -75.47 % -75.64 % -55.96 % -33.56 %
ETNB's Overall Ranking # 3699 # 3048 # 2232 # 3676 # 3404
Seq. Investment Change TTM 1.14 % 5.57 % -6.01 % -0.76 % 3.68 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -450 -387 -367 -289 -175

ETNB Company Profile >> Back to ETNB Roi Comparisons >> See Annual ETNB Return On Investment



Return On Investment ETNB's Ranking
Within: No.
Industry # 277
Sector # 616
Overall # 3699

Return On Investment Statistics
High Average Low
164.54 %
-43.37 %
-111.74 %
(Sep 30 2019)   (Dec 31 2021)



  News about 89bio Inc Return on Investment ROI

89bio, Inc. Ramps Up Capital with $125 Million Public Offering Amid Financial Struggles

November 13, 2024

San Francisco, CA – November 12, 2024 – In a strategic move to bolster its financial standing, clinical-stage biopharmaceutical company 89bio, Inc. (Nasdaq: ETNB) has announced the pricing of an upsized public offering of common stock amounting to $125 million. This announcement comes on the heels of the company’s cumulative net loss of $175 million over the past year, marking a troubling negative return on investment of -33.56%.The offered shares, totaling 11,455,882, will be sold at a public offering price of $8.50 each. In a unique arrangement designed to accommodate certain investors, the company will also offer pre-funded warrants, allowing the purchase of up to 3,250,000 additional shares at a slightly lower price of $8.499. These pre-funded warrants come with an exercise price of just $0.001 per share and can be exercised immediately, presenting an attractive proposition for investors looking for enhanced liquidity.





Financial Statements
89bio Inc's II. Quarter Investments $ 564 Millions ETNB's Balance sheet
89bio Inc's II. Quarter Income $ -112 Millions Quarterly ETNB's Income Statement
ETNB's Income by Division See ETNB's Income by Division


ETNB Annual Return On Investment (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020
Total Investments in Millions 443 567 172 143 203
Y / Y Investment Growth -21.9 % 229.05 % 20.52 % -29.6 % 125.65 %
Net Income in Millions -367 -142 -102 -90 -49
Y / Y Net Income Growth - - - - -
Annual Return On Investment -82.95 % -25.09 % -59.25 % -63.07 % -24.39 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ETNB's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ETNB's Competitors
Subscribers only: Roi for 89bio Inc's Suppliers
Subscribers only: Return On Investment for ETNB's Customers

Other Ratios
ETNB's Roa ETNB's Inventory Turnover Ratio ETNB's Growth Rates ETNB's Dividend Statistics
ETNB's Profitability Ratios ETNB's Asset Turnover Ratio ETNB's Dividend Growth
ETNB's Roe ETNB's Valuation Ratios ETNB's Financial Strength Ratios ETNB's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2025, within Healthcare Sector ROI

Date modified: 2026-09-08T15:11:33+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.